Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2026
Evaluation of false positive enteric viruses results from the BIOFIRE® FILMARRAY® gastrointestinal PCR panel.
СтатьяОценочное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chhabra Preeti, Cates Jordan, Bartlett Eddie, Embury Shane A, Rizwan Amina, Williams Fiancee A, Kambhampati Anita K, Marconi Vincent C, Epstein Lauren, Jasarevic Rijalda, Kraft Colleen S, Rodriguez-Barradas Maria C, Morones Rosalba Gomez, Covarrubias Miguel A, Beenhouwer David O, Goldin Evan, Brown Sheldon T, Pena Ismael, Lucero-Obusan Cynthia A, Holodniy Mark, Gautam Rashi, Mirza Sara A, Vinjé Jan, Surveillance Platform for Enteric and Respiratory Infectious Organisms at the VA (SUPERNOVA) AGE Surveillance Group
Аннотация
BACKGROUND: The BioFire® FilmArray® Gastrointestinal (GI) Panel targets 22 pathogens associated with acute gastroenteritis (AGE). While the Veterans Affairs SUPERNOVA surveillance platform uses this assay to test stool specimens from hospitalized Veterans across five U.S. medical centers, increasing reports of false positives, particularly for norovirus, have raised concerns regarding the assay's accuracy.
OBJECTIVE: To verify BioFire®-positive viral results from the SUPERNOVA study using molecular reference methods at the Centers for Disease Control and Prevention (CDC).
STUDY DESIGN: A total of 415 stool specimens (2018-2023) from both hospitalized and outpatient Veterans with AGE that tested positive by BioFire® GI panel for at least one of five viruses (norovirus, rotavirus, sapovirus, astrovirus, or adenovirus 40/41) were retested using CDC reference methods, including RT-qPCR and conventional RT-PCR with Sanger sequencing. Specimens were considered true positive when confirmed by two of the three testing methods.
RESULTS: Of the 415 specimens, 327 (78.8%) were confirmed positive for at least one virus. Norovirus was the most frequent (n = 207; 63.3%), followed by sapovirus (39; 11.9%), rotavirus A (37; 11.3%), astrovirus (36; 11.0%), and adenovirus 40/41 (10; 3.1%). False-positive rates were highest for norovirus (26.5%), followed by rotavirus (21.3%) and sapovirus (18.8%). Norovirus false-positives were more frequent in hospitalized patients (35.5%) than in outpatients (19.2%), particularly among individuals aged 40-60 years. Norovirus false positives trended upward starting in 2021.
DISCUSSION: These results confirm performance concerns with the BioFire® GI Panel, particularly for norovirus, the most frequently identified virus. Confirmatory testing of questionable positives should be considered.
OBJECTIVE: To verify BioFire®-positive viral results from the SUPERNOVA study using molecular reference methods at the Centers for Disease Control and Prevention (CDC).
STUDY DESIGN: A total of 415 stool specimens (2018-2023) from both hospitalized and outpatient Veterans with AGE that tested positive by BioFire® GI panel for at least one of five viruses (norovirus, rotavirus, sapovirus, astrovirus, or adenovirus 40/41) were retested using CDC reference methods, including RT-qPCR and conventional RT-PCR with Sanger sequencing. Specimens were considered true positive when confirmed by two of the three testing methods.
RESULTS: Of the 415 specimens, 327 (78.8%) were confirmed positive for at least one virus. Norovirus was the most frequent (n = 207; 63.3%), followed by sapovirus (39; 11.9%), rotavirus A (37; 11.3%), astrovirus (36; 11.0%), and adenovirus 40/41 (10; 3.1%). False-positive rates were highest for norovirus (26.5%), followed by rotavirus (21.3%) and sapovirus (18.8%). Norovirus false-positives were more frequent in hospitalized patients (35.5%) than in outpatients (19.2%), particularly among individuals aged 40-60 years. Norovirus false positives trended upward starting in 2021.
DISCUSSION: These results confirm performance concerns with the BioFire® GI Panel, particularly for norovirus, the most frequently identified virus. Confirmatory testing of questionable positives should be considered.